SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Menlo Therapeutics Q1 EPS $(0.950) Misses $(0.540) Estimate

Menlo Therapeutics (NASDAQ:MNLO) reported quarterly losses of $(0.950) per share which missed the analyst consensus estimate of $(0.540) by 75.93 percent. This is a 17.28 percent decrease over losses of $(0.810) per

Benzinga · 05/11/2020 11:15

Menlo Therapeutics (NASDAQ:MNLO) reported quarterly losses of $(0.950) per share which missed the analyst consensus estimate of $(0.540) by 75.93 percent. This is a 17.28 percent decrease over losses of $(0.810) per share from the same period last year.